There are 14 resources available
Vaccine and adoptive cell therapy strategies for the treatment of KRAS mutant NSCLC
Presenter: M. Nagasaka, US
Session: Session 3 – Moving beyond KRAS G12C
Resources:
Slides
Webcast
Liquid biopsy applications for RAS-mutated mutational profiling, monitoring of disease course, clonal evolution and resistance in NSCLC
Presenter: L. Mezquita, ES and K. M. Kerr, UK
Session: Workshop Sessions
Resources:
Webcast
Moving forward with KRAS G12C inhibitors in early stage/locally advanced NSCLC
Presenter: Z. Li, CN and D. S. W. Tan, SG
Session: Workshop Sessions
Resources:
Webcast
Designing practice-changing trials – key considerations
Presenter: M.J. Ahn, KR and F. D. Nicolantonio, IT
Session: Workshop Sessions
Resources:
Webcast